Harvard Bioscience Q2 Adj. EPS $(0.01), Inline, Sales $20.45M Beat $20.40M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Harvard Bioscience (NASDAQ:HBIO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.45 million which beat the analyst consensus estimate
Harvard Bioscience (NASDAQ:HBIO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.45 million which beat the analyst consensus estimate of $20.40 million by 0.25 percent. This is a 11.46 percent decrease over sales of $23.10 million the same period last year.